ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,892Medicare Part D Prescriptions Filled, Including Refills

Rank: 202 out of 1206

$445K Total Retail Price of All Prescriptions

Rank: 226 out of 1206

562 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 562 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 562 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 7,472 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
FUROSEMIDE 366 320 1 5
LISINOPRIL 344 283 2 4
WARFARIN SODIUM 259 217 3 8
SIMVASTATIN 250 189 4 1
HYDROCODONE-ACETAMINOPHEN 250 175 S3 4 7
OMEPRAZOLE 240 201 6 3
POTASSIUM CHLORIDE 234 201 7 12
RANITIDINE HCL 221 141 8 23
METOPROLOL TARTRATE 217 195 9 9
LEVOTHYROXINE SODIUM 212 152 10 2
ATENOLOL 180 158 11 14
CITALOPRAM HBR 174 138 12 16
METFORMIN HCL 173 111 13 10
PREDNISONE 165 124 14 28
MELOXICAM 163 112 15 35
AMLODIPINE BESYLATE 136 122 16 6
TRAMADOL HCL 120 92 17 17
PRAVASTATIN SODIUM 112 68 18 21
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 79 19 82
HYDROCHLOROTHIAZIDE 108 95 20 11
LANTUS 102 61 21 38
LEVOFLOXACIN 92 81 22 78
DONEPEZIL HCL 80 61 23 29
INSULIN SYRINGE 79 44 24 111
GEMFIBROZIL 79 60 24 71
GABAPENTIN 77 61 26 18
METOPROLOL SUCCINATE 77 63 26 15
TRAZODONE HCL 77 62 26 37
CIPROFLOXACIN HCL 76 55 29 61
AZITHROMYCIN 76 64 29 46
DIGOXIN 73 66 31 43
CEPHALEXIN 72 59 32 62
ADVAIR DISKUS 72 61 32 55
GLIMEPIRIDE 72 60 32 34
DOXYCYCLINE HYCLATE 70 52 35 103
CARVEDILOL 68 62 36 32
ATORVASTATIN CALCIUM 67 60 37 13
METOLAZONE 66 51 38 158
COMBIVENT 64 53 39 150
METOCLOPRAMIDE HCL 63 22 40 127
TAMSULOSIN HCL 62 62 41 26
LACTULOSE 62 56 41 124
ALLOPURINOL 61 60 43 24
ACTOS 55 33 44 98
ENALAPRIL MALEATE 55 37 44 45
SERTRALINE HCL 54 49 46 22
PROAIR HFA 53 28 47 49
SINGULAIR 52 42 48 120
BACLOFEN 52 28 48 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.